Entamoeba histolytica has the unusual ability to kill human cells and then wear them as a disguise to escape the immune defenses.

Entamoeba histolytica (green) attacking human T cells. A new paper by UC Davis researchers lays out a strategy for investigating how this parasite can hide from the human immune system while ...

The single-celled parasite Entamoeba histolytica infects 50 million people each year, killing nearly 70,000. Usually, this wily, shape-shifting amoeba causes nothing worse than diarrhea. But sometimes ...

The single-celled parasite Entamoeba histolytica infects 50 million people each year, killing nearly 70,000. Usually, this wily, shape-shifting amoeba causes nothing worse than diarrhea.

The parasitic amoeba Entamoeba histolytica (Fig. 1) infects about 50 million people a year, mostly in developing countries. It causes amebiasis, which has symptoms such as diarrhea, dysentery and ...

The pathogenesis of a potentially fatal amoeba, Entamoeba histolytica (E. histolytica), has been discovered, showing that the organism uses a process coined as trogocytosis, to nibble sections of a ...

The findings, which showed that auranofin inhibited growth of the parasite Entamoeba histolytica in lab tests as well as two rodent models of the disease, highlight the importance of screening ...

Entamoeba histolytica is a protozoan parasite that causes amoebiasis. Recent studies have revealed opportunities to produce an effective vaccine against the Entamoeba histolytica infection.

To the Editor: Paromomycin and diloxanide furoate are the drugs recommended for the treatment of asymptomatic Entamoeba histolytica infection.1 These agents have been used in clinical practice for ...